Subdermal Contraceptive Implants Market Trends

  • Report ID: 5300
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Subdermal Contraceptive Implants Market Trends

Growth Drivers

  • Rising Awareness about Family Planning – As a result, the demand for subdermal contraceptive implants is expected to rise as they have a huge potential to help in family planning, and are one of the most practical, accessible, and increasingly accepted forms of family planning in the world. Globally, more than 60% percent of married women between the ages of 15 and 49 practice family planning.
  • Increasing Knowledge about Contraceptives- Educational interventions across the globe are helping to increase the knowledge of available contraceptive methods, which has led to an increase in the adoption of subdermal contraceptive implants as an acceptable means of contraception for adolescent girls and young women.

Challenges

  • Side Effects of Subdermal Contraceptive Implants- There are a few side effects that some people experience after receiving implants which include menstrual irregularities, headaches, weight gain, acne, dizziness, mood swings, nausea, lower abdominal pain, hair loss, loss of libido, pain at the implant site, neuropathy, and follicular cysts.

Additionally, implanon (etonogestrel) a contraceptive used to prevent pregnancy can cause serious eye symptoms, serious heart symptoms, and severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination. Furthermore, it should not be used at the time of pregnancy as it can lead to a certain serious pregnancy issue (ectopic pregnancy).

  • Lack of Awareness in Developing Regions
  • Lack of Skilled Professionals to Insert and Remove these Implants

Subdermal Contraceptive Implants Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

3.7%

Base Year Market Size (2024)

USD 1.08 billion

Forecast Year Market Size (2037)

USD 1.73 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5300
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of subdermal contraceptive implants is assessed at USD 1.11 billion.

The subdermal contraceptive implants market size was over USD 1.08 billion in 2024 and is likely to reach USD 1.73 billion by the end of 2037, witnessing around 3.7% CAGR during the forecast period i.e., between 2025-2037. Rising count of unintended pregnancies and the rising governmental initiative to utilize contraceptive procedures will drive the market growth.

North America industry is estimated to hold largest revenue share 55% by 2037, impelled by availability of contraceptive implants in the region.

The major players in the market are Shanghai Dahua Pharmaceutical Co., Ltd, Bayer AG, Wyeth Pharmaceuticals, Baxter, Gerresheimer AG, Pfizer, Inc., Novartis AG, Schott AG, Eli Lilly and Company, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample